Companies: 10,795·Total market cap: $144.5T

Plus Therapeutics, Inc.

Plus Therapeutics, Inc.

PSTVNASDAQHealthcare● Active

$5.70

+$0.17(+2.98%)

Market Cap$13779645

P/E Ratio—

52W High$23.5

52W Low$2.9

Avg Volume309K

Open$5.41

Beta1.37

Net Income Financials Revenue

Plus Therapeutics, Inc. (PSTV) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PSTV · net income · updated Jun 9, 2026

Core profitability metrics

PSTV · net income · margin · TTM · CAGR

Net income was −$22.4M for FY2025 (fiscal year ending 2025-12-31), down 72.5% year-over-year. Net profit margin was -429.4%.

FY2025 Net Income−$22.4M▼ -72.5% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin-429.4%−$22.4M ÷ $5.2M

YoY Change-72.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · PSTV net income history · PSTV profit margin

Annual net income data

PSTV · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$22.4M▼ 72.5%-429.4%$5.2M

FY2024Loss−$13.0M▲ +2.5%-222.8%$5.8M

FY2023Loss−$13.3M▲ +34.3%-271.0%$4.9M

FY2022Loss−$20.3M▼ 51.3%-9051.3%$224,000

FY2021Loss−$13.4M▼ 62.6%—$0

Net income vs peers (Healthcare)

PSTV vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Plus Therapeutics, Inc. (PSTV) reported net income of −$22.4M for FY2025 (fiscal year ending 2025-12-31), down 72.5% year-over-year. The net profit margin was -429.4% — meaning the company kept $-4.29 of every dollar of revenue as profit.

Plus Therapeutics, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Plus Therapeutics, Inc.'s net profit margin was -429.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Plus Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from PSTV net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PSTV net income · 4 questions

Plus Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $22.4M for FY2025.

is PSTV profitabledoes PSTV make a profitPSTV profitabilityPSTV profitable company

▸ Source: FMP /income-statement · GAAP · Plus Therapeutics, Inc. · Plus Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026